The prevalence of illicit drug use in intensive cardiac care unit ICCU patients
Written By : Isra Zaman
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2022-08-27 03:45 GMT | Update On 2022-08-27 03:45 GMT
Illicit drug use is associated with a nearly nine-fold greater risk of death or life-threatening emergencies in intensive cardiac care unit (ICCU) patients, according to research presented at ESC Congress 2022.
The ADDICT-ICCU study assessed the prevalence of illicit drug use and the association with in-hospital major adverse events in consecutive patients admitted for acute cardiovascular events. From 7 to 22 April 2021, all consecutive patients admitted to ICCU in 39 centers throughout France provided a urine sample tested for illegal drugs.
A total of 1,499 patients were screened. Reasons for admission included myocardial infarction, acute heart failure, arrhythmias, myocarditis, and pulmonary embolism.10.7% had a positive test for at least one illicit drug.
Patients who used illicit drugs tended to be young:33% of patients under 40 years of age were users compared with just 6% of those aged 60 years or above.
During a median hospitalization of five days, 4.1% had a major adverse event. Illicit drug use was associated with an almost nine-fold odds of major adverse events after adjusting for comorbidities. After adjustment for age and sex, cannabis use was associated with a three-fold odds of major adverse events while cocaine was associated with a five-fold odds. Of those using drugs, 28% took more than one type of drug. Multiple drug use was associated with a higher incidence of major adverse events than single drug use.
Ref:
Dr. Theo Pezel et al, ESC Congress 2022.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.